An educational program aimed at empowering the whole family may help improve mental health for people with multiple sclerosis…
Articles by Marisa Horak, MS
An MRI technique known as APART-QSM may help researchers track signs of repair to the myelin sheath, which is…
A lower dose of the experimental therapy foralumab significantly reduced a marker of brain inflammation in people with nonactive…
Most people with progressive forms of multiple sclerosis (MS) had stable or improved disability scores after receiving the experimental…
Early treatment with the experimental oral therapy vidofludimus calcium (IMU-838) may lead to less long-term disability in people with…
When Christina Applegate was diagnosed with multiple sclerosis (MS) in 2021, she finally had an explanation for the…
Blood levels of neurofilament light chain (NfL), a marker of nerve damage, may help predict the risk of future disease…
Briumvi (ublituximab-xiiy) may be more effective than Kesimpta (ofatumumab) or Ocrevus (ocrelizumab) at preventing disability progression among people with…
Generic medications are expected to be equivalent to their brand-name counterparts — but a new study found that generic versions…
Scientists at the University of Colorado are testing an experimental approach for multiple sclerosis (MS) that uses electrical stimulation…
An experimental therapy called kamuvudine-9 (K-9) reversed established paralysis and vision loss in a mouse model of multiple sclerosis…
In children and adolescents with multiple…
A high-fat diet may lead to worse disability in people with multiple sclerosis (MS) by altering the composition of…
Researchers have identified four key biomarkers in the fluid surrounding the brain and spinal cord that may be used to…
Regulators in the European Union (EU) have recommended that the infusion therapy Ocrevus (ocrelizumab) be approved to treat children…
Tiziana Life Sciences has signed a deal with strategic partners to support a clinical trial designed to test its…
Reactivation of dormant Epstein-Barr virus (EBV) in immune cells may trigger disease flares in multiple sclerosis (MS), a…
The U.S. Food and Drug Administration (FDA) has given Abelzeta Pharma the go-ahead to launch an early-stage clinical trial…
Among people with multiple sclerosis (MS), overall quality of life may be closely associated with walking ability, according to…
People whose dietary habits are more in line with a Mediterranean-style diet may be less likely to develop multiple…
Multiple sclerosis (MS) may be marked by problems with the body’s ability to make new mitochondria — the small…
People with multiple sclerosis (MS) who report difficulty sleeping tend to have reduced flow in what essentially serves as…
A new experimental cell therapy that pairs a patient’s own red blood cells with myelin protein fragments safely calmed the…
An experimental oral drug called remibrutinib outperformed the approved therapy Aubagio (teriflunomide) in reducing disease flare rates in…
Anti-inflammatory diets may help to ease fatigue and improve overall physical health in people with multiple sclerosis (MS), according…
Both the Mediterranean diet and time-restricted eating — a dietary intervention in which all daily meals and snacks are consumed…
Scientists have identified dozens of genes in specific immune cells that may influence the risk of…
A trio of scientists in Australia has developed a mathematical model that can be used to help understand disease activity…
In people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with poorer cognitive function, while higher levels…
Concussions during adolescence may increase the risk of developing multiple sclerosis (MS), but only if the concussion occurs before…